Teton Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,000
Closed -$218K 162
2026
Q1
$218K Buy
+2,000
New +$191K 0.15% 122
2025
Q3
Sell
-2,500
Closed -$208K 166
2025
Q2
$208K Sell
2,500
-500
-17% -$41.8K 0.13% 162
2025
Q1
$252K Sell
3,000
-1,854
-38% -$172K 0.16% 138
2024
Q4
$447K Hold
4,854
0.23% 118
2024
Q3
$451K Sell
4,854
-646
-12% -$56K 0.2% 125
2024
Q2
$453K Hold
5,500
0.19% 130
2024
Q1
$365K Hold
5,500
0.13% 153
2023
Q4
$312K Hold
5,500
0.1% 172
2023
Q3
$300K Hold
5,500
0.09% 182
2023
Q2
$370K Hold
5,500
0.1% 180
2023
Q1
$283K Hold
5,500
0.08% 208
2022
Q4
$253K Hold
5,500
0.06% 226
2022
Q3
$279K Hold
5,500
0.07% 232
2022
Q2
$251K Hold
5,500
0.05% 249
2022
Q1
$256K Hold
5,500
0.04% 275
2021
Q4
$276K Hold
5,500
0.04% 346
2021
Q3
$292K Hold
5,500
0.04% 343
2021
Q2
$336K Hold
5,500
0.04% 327
2021
Q1
$268K Hold
5,500
0.04% 331
2020
Q4
$223K Buy
+5,500
New +$197K 0.03% 361

Other funds holding LMAT

Teton Advisors's LMAT Position: Q2 2026 in Review

Teton Advisors sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 2,000 shares — an estimated $218K sold.

Teton Advisors first reported a position in LMAT in Q4 2020 and held it in 20 quarters. The position peaked at $453K in Q2 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Teton Advisors reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Teton Advisors sold 2,000 LeMaitre Vascular shares in Q2 2026, an estimated $218K.
  • Teton Advisors first reported a position in LeMaitre Vascular in Q4 2020 and held it in 20 quarters.
  • Teton Advisors's LeMaitre Vascular position peaked at $453K in Q2 2024.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Teton Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.